Nanomedicine Combats Drug Resistance in Lung Cancer

Author:

Zheng Xiuli1ORCID,Song Xiaohai2ORCID,Zhu Guonian1,Pan Dayi1,Li Haonan1,Hu Jiankun2,Xiao Kai1,Gong Qiyong134ORCID,Gu Zhongwei1ORCID,Luo Kui13ORCID,Li Weimin13ORCID

Affiliation:

1. Department of Radiology Department of Respiratory Huaxi MR Research Center (HMRRC) and Critical Care Medicine Institute of Respiratory Health Precision Medicine Center Frontiers Science Center for Disease‐Related Molecular Network State Key Laboratory of Biotherapy West China Hospital Sichuan University No. 37 Guoxue Alley Chengdu 610041 China

2. Department of General Surgery Gastric Cancer Center and Laboratory of Gastric Cancer West China Hospital Sichuan University No. 37 Guoxue Alley Chengdu 610041 China

3. Precision Medicine Key Laboratory of Sichuan Province Functional and Molecular Imaging Key Laboratory of Sichuan Province and Research Unit of Psychoradiology Chinese Academy of Medical Sciences Chengdu 610041 China

4. Department of Radiology West China Xiamen Hospital of Sichuan University Xiamen Fujian 361000 China

Abstract

AbstractLung cancer is the second most prevalent cancer and the leading cause of cancer‐related death worldwide. Surgery, chemotherapy, molecular targeted therapy, immunotherapy, and radiotherapy are currently available as treatment methods. However, drug resistance is a significant factor in the failure of lung cancer treatments. Novel therapeutics have been exploited to address complicated resistance mechanisms of lung cancer and the advancement of nanomedicine is extremely promising in terms of overcoming drug resistance. Nanomedicine equipped with multifunctional and tunable physiochemical properties in alignment with tumor genetic profiles can achieve precise, safe, and effective treatment while minimizing or eradicating drug resistance in cancer. Here, this work reviews the discovered resistance mechanisms for lung cancer chemotherapy, molecular targeted therapy, immunotherapy, and radiotherapy, and outlines novel strategies for the development of nanomedicine against drug resistance. This work focuses on engineering design, customized delivery, current challenges, and clinical translation of nanomedicine in the application of resistant lung cancer.

Funder

National Natural Science Foundation of China

National Postdoctoral Program for Innovative Talents

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3